- Fertility & Reproductive Systems
Birth Control Pills: Warning! Risk of Blood Clots!
New Generation Birth-Control Pills: Danger!
There could be danger in those new birth-control pills that are now on the market, like Yaz and Yasmin, and the FDA is concerned.
An FDA study found that there is a higher risk of developing blood clots, venous thromboembolisms (VTEs), especially in women who are under 35, and who are taking Yasmin. A similar conclusion was drawn about Johnson & Johnson's birth-control pill, Ortho Evra.
A study also reported a higher risk of arterial thrombotic events (ATEs), in older women on Yasmin. The problem is that VTEs and ATEs are dangerous and can significantly increase the risk of strokes or death!
Cynthia Pearson, of the National Women's Health Network, is just one of the consumer advocacy groups who want the drugs off the market. She said, "While it's rare, it's heartbreaking when this happens. When there are safer options available, we can't let this continue..."
The new birth-control pills contain drospirenone, which may be the culprit but researchers aren't sure because there are too many conflicting factors.
For example, a woman taking an older version of birth-control pills may also experience clots as she ages, and especially if she smokes, etc. Also, Johnson's Ortho Evra does not contain drospirenone, yet those who use it are at a higher risk for developing clots, the study found.
Unsafe Birth-Control Pills: The Solution!
If you are taking these new-generation birth-control pills, you need to call your health-care provider immediately.
It only makes sense to switch your birth control until more research is done and scientists find out the reason for the higher risk of developing blood clots when taking these types of birth-control pills!
Don't waste time!
CAUTION: The information included herein is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice. The reader should always consult his or her healthcare provider to determine the appropriateness of the information for their own situation or if they have any questions regarding a medical condition or treatment plan.